nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenac—CYP1A1—Riluzole—amyotrophic lateral sclerosis	0.279	0.691	CbGbCtD
Diclofenac—PTGS2—amyotrophic lateral sclerosis	0.21	1	CbGaD
Diclofenac—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.125	0.309	CbGbCtD
Diclofenac—Proctitis—Riluzole—amyotrophic lateral sclerosis	0.00587	0.0291	CcSEcCtD
Diclofenac—Skin nodule—Riluzole—amyotrophic lateral sclerosis	0.00516	0.0256	CcSEcCtD
Diclofenac—Rheumatoid arthritis—Riluzole—amyotrophic lateral sclerosis	0.00474	0.0236	CcSEcCtD
Diclofenac—Skin mass—Riluzole—amyotrophic lateral sclerosis	0.00462	0.0229	CcSEcCtD
Diclofenac—Dental caries—Riluzole—amyotrophic lateral sclerosis	0.00385	0.0191	CcSEcCtD
Diclofenac—PLA2G2A—tongue—amyotrophic lateral sclerosis	0.00363	0.0589	CbGeAlD
Diclofenac—TTR—peripheral nervous system—amyotrophic lateral sclerosis	0.0036	0.0584	CbGeAlD
Diclofenac—Furunculosis—Riluzole—amyotrophic lateral sclerosis	0.00337	0.0167	CcSEcCtD
Diclofenac—Hernia—Riluzole—amyotrophic lateral sclerosis	0.00305	0.0152	CcSEcCtD
Diclofenac—Endophthalmitis—Riluzole—amyotrophic lateral sclerosis	0.00301	0.0149	CcSEcCtD
Diclofenac—Furuncle—Riluzole—amyotrophic lateral sclerosis	0.00292	0.0145	CcSEcCtD
Diclofenac—Platelet count decreased—Riluzole—amyotrophic lateral sclerosis	0.00241	0.012	CcSEcCtD
Diclofenac—Myasthenia—Riluzole—amyotrophic lateral sclerosis	0.00228	0.0113	CcSEcCtD
Diclofenac—Hypokinesia—Riluzole—amyotrophic lateral sclerosis	0.00212	0.0105	CcSEcCtD
Diclofenac—Seborrhoeic dermatitis—Riluzole—amyotrophic lateral sclerosis	0.0021	0.0104	CcSEcCtD
Diclofenac—TTR—hindbrain—amyotrophic lateral sclerosis	0.0021	0.0341	CbGeAlD
Diclofenac—Hyperventilation—Riluzole—amyotrophic lateral sclerosis	0.00208	0.0103	CcSEcCtD
Diclofenac—Blood creatine phosphokinase increased—Riluzole—amyotrophic lateral sclerosis	0.00208	0.0103	CcSEcCtD
Diclofenac—Haematemesis—Riluzole—amyotrophic lateral sclerosis	0.00206	0.0102	CcSEcCtD
Diclofenac—Laryngitis—Riluzole—amyotrophic lateral sclerosis	0.00199	0.00987	CcSEcCtD
Diclofenac—KCNQ2—brainstem—amyotrophic lateral sclerosis	0.00194	0.0314	CbGeAlD
Diclofenac—Neuritis—Riluzole—amyotrophic lateral sclerosis	0.00192	0.00953	CcSEcCtD
Diclofenac—Respiratory depression—Riluzole—amyotrophic lateral sclerosis	0.0019	0.00945	CcSEcCtD
Diclofenac—Pulmonary function test decreased—Riluzole—amyotrophic lateral sclerosis	0.0019	0.00945	CcSEcCtD
Diclofenac—Amblyopia—Riluzole—amyotrophic lateral sclerosis	0.00185	0.00921	CcSEcCtD
Diclofenac—ASIC1—medulla oblongata—amyotrophic lateral sclerosis	0.00185	0.0299	CbGeAlD
Diclofenac—Skin ulcer—Riluzole—amyotrophic lateral sclerosis	0.00184	0.00914	CcSEcCtD
Diclofenac—ASIC1—spinal cord—amyotrophic lateral sclerosis	0.00165	0.0267	CbGeAlD
Diclofenac—Accidental injury—Riluzole—amyotrophic lateral sclerosis	0.00162	0.00804	CcSEcCtD
Diclofenac—PTGS2—hindlimb—amyotrophic lateral sclerosis	0.0016	0.026	CbGeAlD
Diclofenac—Musculoskeletal stiffness—Riluzole—amyotrophic lateral sclerosis	0.0016	0.00793	CcSEcCtD
Diclofenac—Ventricular extrasystoles—Riluzole—amyotrophic lateral sclerosis	0.00159	0.00787	CcSEcCtD
Diclofenac—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.00158	0.00782	CcSEcCtD
Diclofenac—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.00156	0.00777	CcSEcCtD
Diclofenac—Cough increased—Riluzole—amyotrophic lateral sclerosis	0.00156	0.00777	CcSEcCtD
Diclofenac—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.00155	0.00772	CcSEcCtD
Diclofenac—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.00154	0.00767	CcSEcCtD
Diclofenac—Gout—Riluzole—amyotrophic lateral sclerosis	0.00153	0.00762	CcSEcCtD
Diclofenac—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.00151	0.00752	CcSEcCtD
Diclofenac—Ulcer—Riluzole—amyotrophic lateral sclerosis	0.00151	0.00752	CcSEcCtD
Diclofenac—Cataract—Riluzole—amyotrophic lateral sclerosis	0.0015	0.00747	CcSEcCtD
Diclofenac—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.00147	0.00729	CcSEcCtD
Diclofenac—KCNQ3—medulla oblongata—amyotrophic lateral sclerosis	0.00147	0.0238	CbGeAlD
Diclofenac—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.00146	0.00724	CcSEcCtD
Diclofenac—Neck pain—Riluzole—amyotrophic lateral sclerosis	0.00145	0.0072	CcSEcCtD
Diclofenac—Hepatocellular injury—Riluzole—amyotrophic lateral sclerosis	0.00143	0.00711	CcSEcCtD
Diclofenac—Injection site reaction—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00707	CcSEcCtD
Diclofenac—Dermatitis contact—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00703	CcSEcCtD
Diclofenac—Melaena—Riluzole—amyotrophic lateral sclerosis	0.0014	0.00695	CcSEcCtD
Diclofenac—ASIC1—nervous system—amyotrophic lateral sclerosis	0.00139	0.0225	CbGeAlD
Diclofenac—PTGS2—appendage—amyotrophic lateral sclerosis	0.00138	0.0223	CbGeAlD
Diclofenac—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.00136	0.00675	CcSEcCtD
Diclofenac—Aplastic anaemia—Riluzole—amyotrophic lateral sclerosis	0.00134	0.00668	CcSEcCtD
Diclofenac—ASIC1—central nervous system—amyotrophic lateral sclerosis	0.00133	0.0216	CbGeAlD
Diclofenac—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00653	CcSEcCtD
Diclofenac—TTR—embryo—amyotrophic lateral sclerosis	0.00131	0.0213	CbGeAlD
Diclofenac—Coma—Riluzole—amyotrophic lateral sclerosis	0.00131	0.0065	CcSEcCtD
Diclofenac—ASIC1—cerebellum—amyotrophic lateral sclerosis	0.0013	0.0212	CbGeAlD
Diclofenac—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00643	CcSEcCtD
Diclofenac—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.00126	0.00623	CcSEcCtD
Diclofenac—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00617	CcSEcCtD
Diclofenac—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00617	CcSEcCtD
Diclofenac—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00605	CcSEcCtD
Diclofenac—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00605	CcSEcCtD
Diclofenac—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00599	CcSEcCtD
Diclofenac—TTR—brainstem—amyotrophic lateral sclerosis	0.0012	0.0195	CbGeAlD
Diclofenac—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.00119	0.00591	CcSEcCtD
Diclofenac—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00588	CcSEcCtD
Diclofenac—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00116	0.00577	CcSEcCtD
Diclofenac—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00116	0.00577	CcSEcCtD
Diclofenac—Eczema—Riluzole—amyotrophic lateral sclerosis	0.00116	0.00574	CcSEcCtD
Diclofenac—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00569	CcSEcCtD
Diclofenac—Injury—Riluzole—amyotrophic lateral sclerosis	0.00113	0.00562	CcSEcCtD
Diclofenac—KCNQ3—nervous system—amyotrophic lateral sclerosis	0.0011	0.0179	CbGeAlD
Diclofenac—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00547	CcSEcCtD
Diclofenac—CXCL8—medulla oblongata—amyotrophic lateral sclerosis	0.0011	0.0179	CbGeAlD
Diclofenac—Thirst—Riluzole—amyotrophic lateral sclerosis	0.00109	0.00542	CcSEcCtD
Diclofenac—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00108	0.00536	CcSEcCtD
Diclofenac—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00533	CcSEcCtD
Diclofenac—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00531	CcSEcCtD
Diclofenac—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00529	CcSEcCtD
Diclofenac—KCNQ3—central nervous system—amyotrophic lateral sclerosis	0.00106	0.0172	CbGeAlD
Diclofenac—ASIC1—brain—amyotrophic lateral sclerosis	0.00106	0.0172	CbGeAlD
Diclofenac—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00516	CcSEcCtD
Diclofenac—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00516	CcSEcCtD
Diclofenac—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00516	CcSEcCtD
Diclofenac—KCNQ3—cerebellum—amyotrophic lateral sclerosis	0.00104	0.0168	CbGeAlD
Diclofenac—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00508	CcSEcCtD
Diclofenac—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00504	CcSEcCtD
Diclofenac—KCNQ2—nervous system—amyotrophic lateral sclerosis	0.00101	0.0165	CbGeAlD
Diclofenac—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.001	0.00498	CcSEcCtD
Diclofenac—CXCL8—spinal cord—amyotrophic lateral sclerosis	0.000982	0.0159	CbGeAlD
Diclofenac—KCNQ2—central nervous system—amyotrophic lateral sclerosis	0.000977	0.0158	CbGeAlD
Diclofenac—KCNQ2—cerebellum—amyotrophic lateral sclerosis	0.000955	0.0155	CbGeAlD
Diclofenac—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.000936	0.00465	CcSEcCtD
Diclofenac—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00092	0.00457	CcSEcCtD
Diclofenac—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.000917	0.00455	CcSEcCtD
Diclofenac—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.000917	0.00455	CcSEcCtD
Diclofenac—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.000905	0.00449	CcSEcCtD
Diclofenac—Asthma—Riluzole—amyotrophic lateral sclerosis	0.000899	0.00446	CcSEcCtD
Diclofenac—Influenza—Riluzole—amyotrophic lateral sclerosis	0.000899	0.00446	CcSEcCtD
Diclofenac—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.000881	0.00437	CcSEcCtD
Diclofenac—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.000875	0.00435	CcSEcCtD
Diclofenac—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.000864	0.00429	CcSEcCtD
Diclofenac—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000862	0.00428	CcSEcCtD
Diclofenac—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.000853	0.00424	CcSEcCtD
Diclofenac—KCNQ3—brain—amyotrophic lateral sclerosis	0.000843	0.0137	CbGeAlD
Diclofenac—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00084	0.00417	CcSEcCtD
Diclofenac—TTR—medulla oblongata—amyotrophic lateral sclerosis	0.00084	0.0136	CbGeAlD
Diclofenac—SLCO1C1—spinal cord—amyotrophic lateral sclerosis	0.000837	0.0136	CbGeAlD
Diclofenac—PLA2G2A—nervous system—amyotrophic lateral sclerosis	0.000836	0.0136	CbGeAlD
Diclofenac—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00083	0.00412	CcSEcCtD
Diclofenac—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.000828	0.00411	CcSEcCtD
Diclofenac—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00082	0.00407	CcSEcCtD
Diclofenac—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.000818	0.00406	CcSEcCtD
Diclofenac—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.000813	0.00404	CcSEcCtD
Diclofenac—Bromfenac—PTGS2—amyotrophic lateral sclerosis	0.000809	0.261	CrCbGaD
Diclofenac—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.000806	0.004	CcSEcCtD
Diclofenac—PLA2G2A—central nervous system—amyotrophic lateral sclerosis	0.000804	0.013	CbGeAlD
Diclofenac—Infestation—Riluzole—amyotrophic lateral sclerosis	0.000801	0.00398	CcSEcCtD
Diclofenac—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.000801	0.00398	CcSEcCtD
Diclofenac—Depression—Riluzole—amyotrophic lateral sclerosis	0.000799	0.00397	CcSEcCtD
Diclofenac—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00079	0.00392	CcSEcCtD
Diclofenac—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.000785	0.0039	CcSEcCtD
Diclofenac—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.000785	0.0039	CcSEcCtD
Diclofenac—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.000781	0.00388	CcSEcCtD
Diclofenac—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.000781	0.00388	CcSEcCtD
Diclofenac—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.000779	0.00387	CcSEcCtD
Diclofenac—CXCL8—cerebellum—amyotrophic lateral sclerosis	0.000778	0.0126	CbGeAlD
Diclofenac—KCNQ2—brain—amyotrophic lateral sclerosis	0.000776	0.0126	CbGeAlD
Diclofenac—Sweating—Riluzole—amyotrophic lateral sclerosis	0.000768	0.00381	CcSEcCtD
Diclofenac—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.000764	0.00379	CcSEcCtD
Diclofenac—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.000758	0.00376	CcSEcCtD
Diclofenac—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.000756	0.00375	CcSEcCtD
Diclofenac—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.000752	0.00373	CcSEcCtD
Diclofenac—TTR—spinal cord—amyotrophic lateral sclerosis	0.000749	0.0121	CbGeAlD
Diclofenac—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.000748	0.00371	CcSEcCtD
Diclofenac—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.000732	0.00364	CcSEcCtD
Diclofenac—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.000723	0.00359	CcSEcCtD
Diclofenac—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.000721	0.00358	CcSEcCtD
Diclofenac—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.000719	0.00357	CcSEcCtD
Diclofenac—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.000719	0.00357	CcSEcCtD
Diclofenac—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.000716	0.00355	CcSEcCtD
Diclofenac—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.000716	0.00355	CcSEcCtD
Diclofenac—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.000714	0.00354	CcSEcCtD
Diclofenac—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00071	0.00353	CcSEcCtD
Diclofenac—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.000709	0.00352	CcSEcCtD
Diclofenac—SLCO1C1—nervous system—amyotrophic lateral sclerosis	0.000706	0.0114	CbGeAlD
Diclofenac—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.000705	0.0035	CcSEcCtD
Diclofenac—Lumiracoxib—PTGS2—amyotrophic lateral sclerosis	0.000688	0.222	CrCbGaD
Diclofenac—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00068	0.00338	CcSEcCtD
Diclofenac—SLCO1C1—central nervous system—amyotrophic lateral sclerosis	0.000679	0.011	CbGeAlD
Diclofenac—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.000672	0.00334	CcSEcCtD
Diclofenac—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.000668	0.00331	CcSEcCtD
Diclofenac—Nepafenac—PTGS2—amyotrophic lateral sclerosis	0.000654	0.211	CrCbGaD
Diclofenac—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.000653	0.00324	CcSEcCtD
Diclofenac—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00065	0.00323	CcSEcCtD
Diclofenac—SCN4A—nervous system—amyotrophic lateral sclerosis	0.000648	0.0105	CbGeAlD
Diclofenac—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000648	0.00322	CcSEcCtD
Diclofenac—Chills—Riluzole—amyotrophic lateral sclerosis	0.000645	0.0032	CcSEcCtD
Diclofenac—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.000643	0.00319	CcSEcCtD
Diclofenac—PLA2G2A—brain—amyotrophic lateral sclerosis	0.000639	0.0104	CbGeAlD
Diclofenac—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.000636	0.00316	CcSEcCtD
Diclofenac—CXCL8—brain—amyotrophic lateral sclerosis	0.000632	0.0103	CbGeAlD
Diclofenac—TTR—nervous system—amyotrophic lateral sclerosis	0.000631	0.0102	CbGeAlD
Diclofenac—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00063	0.00313	CcSEcCtD
Diclofenac—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.000626	0.00311	CcSEcCtD
Diclofenac—SCN4A—central nervous system—amyotrophic lateral sclerosis	0.000624	0.0101	CbGeAlD
Diclofenac—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.000617	0.00306	CcSEcCtD
Diclofenac—Tension—Riluzole—amyotrophic lateral sclerosis	0.000614	0.00305	CcSEcCtD
Diclofenac—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.000613	0.00304	CcSEcCtD
Diclofenac—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.000608	0.00302	CcSEcCtD
Diclofenac—TTR—central nervous system—amyotrophic lateral sclerosis	0.000607	0.00985	CbGeAlD
Diclofenac—Back pain—Riluzole—amyotrophic lateral sclerosis	0.000606	0.00301	CcSEcCtD
Diclofenac—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.000602	0.00299	CcSEcCtD
Diclofenac—TTR—cerebellum—amyotrophic lateral sclerosis	0.000594	0.00963	CbGeAlD
Diclofenac—Tremor—Riluzole—amyotrophic lateral sclerosis	0.000587	0.00291	CcSEcCtD
Diclofenac—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.000581	0.00288	CcSEcCtD
Diclofenac—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.000579	0.00287	CcSEcCtD
Diclofenac—Agitation—Riluzole—amyotrophic lateral sclerosis	0.000575	0.00286	CcSEcCtD
Diclofenac—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.000572	0.00284	CcSEcCtD
Diclofenac—ALOX5—nervous system—amyotrophic lateral sclerosis	0.000572	0.00927	CbGeAlD
Diclofenac—Malaise—Riluzole—amyotrophic lateral sclerosis	0.000565	0.0028	CcSEcCtD
Diclofenac—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.000563	0.00279	CcSEcCtD
Diclofenac—Syncope—Riluzole—amyotrophic lateral sclerosis	0.000562	0.00279	CcSEcCtD
Diclofenac—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00056	0.00278	CcSEcCtD
Diclofenac—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.000553	0.00275	CcSEcCtD
Diclofenac—ALOX5—central nervous system—amyotrophic lateral sclerosis	0.00055	0.00893	CbGeAlD
Diclofenac—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00055	0.00273	CcSEcCtD
Diclofenac—Cough—Riluzole—amyotrophic lateral sclerosis	0.000546	0.00271	CcSEcCtD
Diclofenac—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.000543	0.00269	CcSEcCtD
Diclofenac—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.000541	0.00268	CcSEcCtD
Diclofenac—SLCO1C1—brain—amyotrophic lateral sclerosis	0.000539	0.00875	CbGeAlD
Diclofenac—ALOX5—cerebellum—amyotrophic lateral sclerosis	0.000538	0.00872	CbGeAlD
Diclofenac—Meclofenamic acid—PTGS2—amyotrophic lateral sclerosis	0.000536	0.173	CrCbGaD
Diclofenac—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.000533	0.00265	CcSEcCtD
Diclofenac—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.000533	0.00265	CcSEcCtD
Diclofenac—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.000533	0.00265	CcSEcCtD
Diclofenac—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.000531	0.00264	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.000529	0.00263	CcSEcCtD
Diclofenac—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.000527	0.00262	CcSEcCtD
Diclofenac—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.000521	0.00259	CcSEcCtD
Diclofenac—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000515	0.00256	CcSEcCtD
Diclofenac—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.000511	0.00254	CcSEcCtD
Diclofenac—Oedema—Riluzole—amyotrophic lateral sclerosis	0.000511	0.00254	CcSEcCtD
Diclofenac—Infection—Riluzole—amyotrophic lateral sclerosis	0.000508	0.00252	CcSEcCtD
Diclofenac—Shock—Riluzole—amyotrophic lateral sclerosis	0.000503	0.0025	CcSEcCtD
Diclofenac—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.000501	0.00249	CcSEcCtD
Diclofenac—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.0005	0.00248	CcSEcCtD
Diclofenac—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000499	0.00248	CcSEcCtD
Diclofenac—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.000496	0.00246	CcSEcCtD
Diclofenac—SCN4A—brain—amyotrophic lateral sclerosis	0.000496	0.00804	CbGeAlD
Diclofenac—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000494	0.00245	CcSEcCtD
Diclofenac—SLC22A6—brain—amyotrophic lateral sclerosis	0.000494	0.00801	CbGeAlD
Diclofenac—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.000487	0.00242	CcSEcCtD
Diclofenac—TTR—brain—amyotrophic lateral sclerosis	0.000482	0.00782	CbGeAlD
Diclofenac—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000478	0.00237	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000466	0.00231	CcSEcCtD
Diclofenac—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000462	0.0023	CcSEcCtD
Diclofenac—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000459	0.00228	CcSEcCtD
Diclofenac—PTGS2—embryo—amyotrophic lateral sclerosis	0.000457	0.00741	CbGeAlD
Diclofenac—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000456	0.00226	CcSEcCtD
Diclofenac—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000454	0.00226	CcSEcCtD
Diclofenac—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00045	0.00223	CcSEcCtD
Diclofenac—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000444	0.00221	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000441	0.00219	CcSEcCtD
Diclofenac—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000441	0.00219	CcSEcCtD
Diclofenac—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000437	0.00217	CcSEcCtD
Diclofenac—Pain—Riluzole—amyotrophic lateral sclerosis	0.000437	0.00217	CcSEcCtD
Diclofenac—ALOX5—brain—amyotrophic lateral sclerosis	0.000437	0.00709	CbGeAlD
Diclofenac—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000421	0.00209	CcSEcCtD
Diclofenac—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000418	0.00207	CcSEcCtD
Diclofenac—Mefenamic acid—PTGS2—amyotrophic lateral sclerosis	0.000417	0.134	CrCbGaD
Diclofenac—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000406	0.00202	CcSEcCtD
Diclofenac—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000404	0.00201	CcSEcCtD
Diclofenac—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000404	0.00201	CcSEcCtD
Diclofenac—ABCC4—nervous system—amyotrophic lateral sclerosis	0.00039	0.00632	CbGeAlD
Diclofenac—SLC22A8—nervous system—amyotrophic lateral sclerosis	0.000387	0.00627	CbGeAlD
Diclofenac—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000377	0.00187	CcSEcCtD
Diclofenac—ABCC4—central nervous system—amyotrophic lateral sclerosis	0.000375	0.00609	CbGeAlD
Diclofenac—SLC22A8—central nervous system—amyotrophic lateral sclerosis	0.000372	0.00604	CbGeAlD
Diclofenac—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000367	0.00182	CcSEcCtD
Diclofenac—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000362	0.0018	CcSEcCtD
Diclofenac—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00035	0.00174	CcSEcCtD
Diclofenac—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000338	0.00168	CcSEcCtD
Diclofenac—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000325	0.00161	CcSEcCtD
Diclofenac—Rash—Riluzole—amyotrophic lateral sclerosis	0.000322	0.0016	CcSEcCtD
Diclofenac—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000322	0.0016	CcSEcCtD
Diclofenac—Headache—Riluzole—amyotrophic lateral sclerosis	0.00032	0.00159	CcSEcCtD
Diclofenac—CYP2E1—medulla oblongata—amyotrophic lateral sclerosis	0.000317	0.00514	CbGeAlD
Diclofenac—ABCC1—cerebellum—amyotrophic lateral sclerosis	0.000313	0.00507	CbGeAlD
Diclofenac—ALB—brain—amyotrophic lateral sclerosis	0.000308	0.00499	CbGeAlD
Diclofenac—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000304	0.00151	CcSEcCtD
Diclofenac—ABCC4—brain—amyotrophic lateral sclerosis	0.000298	0.00483	CbGeAlD
Diclofenac—SLC22A8—brain—amyotrophic lateral sclerosis	0.000296	0.00479	CbGeAlD
Diclofenac—PTGS2—medulla oblongata—amyotrophic lateral sclerosis	0.000292	0.00473	CbGeAlD
Diclofenac—CYP2E1—spinal cord—amyotrophic lateral sclerosis	0.000283	0.00458	CbGeAlD
Diclofenac—ABCB1—embryo—amyotrophic lateral sclerosis	0.000283	0.00458	CbGeAlD
Diclofenac—PTGS1—spinal cord—amyotrophic lateral sclerosis	0.000272	0.00442	CbGeAlD
Diclofenac—CYP1A1—nervous system—amyotrophic lateral sclerosis	0.000261	0.00424	CbGeAlD
Diclofenac—PTGS2—spinal cord—amyotrophic lateral sclerosis	0.00026	0.00422	CbGeAlD
Diclofenac—ABCC1—brain—amyotrophic lateral sclerosis	0.000254	0.00412	CbGeAlD
Diclofenac—CYP2B6—nervous system—amyotrophic lateral sclerosis	0.000254	0.00412	CbGeAlD
Diclofenac—CYP1A1—central nervous system—amyotrophic lateral sclerosis	0.000251	0.00408	CbGeAlD
Diclofenac—CYP2B6—central nervous system—amyotrophic lateral sclerosis	0.000244	0.00396	CbGeAlD
Diclofenac—CYP2E1—nervous system—amyotrophic lateral sclerosis	0.000238	0.00386	CbGeAlD
Diclofenac—PTGS1—nervous system—amyotrophic lateral sclerosis	0.000229	0.00372	CbGeAlD
Diclofenac—CYP2E1—central nervous system—amyotrophic lateral sclerosis	0.000229	0.00372	CbGeAlD
Diclofenac—CYP2E1—cerebellum—amyotrophic lateral sclerosis	0.000224	0.00364	CbGeAlD
Diclofenac—PTGS1—central nervous system—amyotrophic lateral sclerosis	0.000221	0.00358	CbGeAlD
Diclofenac—PTGS2—nervous system—amyotrophic lateral sclerosis	0.000219	0.00356	CbGeAlD
Diclofenac—CYP2C8—brain—amyotrophic lateral sclerosis	0.000216	0.00351	CbGeAlD
Diclofenac—PTGS2—central nervous system—amyotrophic lateral sclerosis	0.000211	0.00342	CbGeAlD
Diclofenac—PTGS2—cerebellum—amyotrophic lateral sclerosis	0.000206	0.00335	CbGeAlD
Diclofenac—CYP1A1—brain—amyotrophic lateral sclerosis	0.0002	0.00324	CbGeAlD
Diclofenac—CYP2B6—brain—amyotrophic lateral sclerosis	0.000194	0.00315	CbGeAlD
Diclofenac—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000192	0.00311	CbGeAlD
Diclofenac—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000185	0.00299	CbGeAlD
Diclofenac—CYP2E1—brain—amyotrophic lateral sclerosis	0.000182	0.00295	CbGeAlD
Diclofenac—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000181	0.00293	CbGeAlD
Diclofenac—PTGS1—brain—amyotrophic lateral sclerosis	0.000175	0.00284	CbGeAlD
Diclofenac—PTGS2—brain—amyotrophic lateral sclerosis	0.000168	0.00272	CbGeAlD
Diclofenac—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000161	0.00261	CbGeAlD
Diclofenac—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000136	0.0022	CbGeAlD
Diclofenac—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.000131	0.00212	CbGeAlD
Diclofenac—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.000128	0.00207	CbGeAlD
Diclofenac—ABCB1—brain—amyotrophic lateral sclerosis	0.000104	0.00168	CbGeAlD
Diclofenac—PTGS2—Metabolism—DAO—amyotrophic lateral sclerosis	2.92e-05	0.000243	CbGpPWpGaD
Diclofenac—ALB—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	2.9e-05	0.000242	CbGpPWpGaD
Diclofenac—ALB—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	2.9e-05	0.000242	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.88e-05	0.00024	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—FIG4—amyotrophic lateral sclerosis	2.86e-05	0.000239	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	2.86e-05	0.000239	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	2.86e-05	0.000239	CbGpPWpGaD
Diclofenac—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	2.84e-05	0.000237	CbGpPWpGaD
Diclofenac—ALB—Folate Metabolism—TP53—amyotrophic lateral sclerosis	2.83e-05	0.000236	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.81e-05	0.000234	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—DAO—amyotrophic lateral sclerosis	2.81e-05	0.000234	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.79e-05	0.000233	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.79e-05	0.000232	CbGpPWpGaD
Diclofenac—ALB—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.78e-05	0.000232	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.77e-05	0.000231	CbGpPWpGaD
Diclofenac—TTR—Disease—APOE—amyotrophic lateral sclerosis	2.77e-05	0.000231	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—DAO—amyotrophic lateral sclerosis	2.75e-05	0.000229	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.73e-05	0.000228	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—APOE—amyotrophic lateral sclerosis	2.7e-05	0.000225	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	2.68e-05	0.000224	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	2.68e-05	0.000223	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	2.67e-05	0.000223	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	2.67e-05	0.000223	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PLB1—amyotrophic lateral sclerosis	2.64e-05	0.00022	CbGpPWpGaD
Diclofenac—CXCL8—Cellular responses to stress—TP53—amyotrophic lateral sclerosis	2.63e-05	0.00022	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	2.63e-05	0.000219	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	2.62e-05	0.000218	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.62e-05	0.000218	CbGpPWpGaD
Diclofenac—ALB—Metabolism—FIG4—amyotrophic lateral sclerosis	2.61e-05	0.000218	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	2.6e-05	0.000217	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—CHAT—amyotrophic lateral sclerosis	2.59e-05	0.000216	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—DAO—amyotrophic lateral sclerosis	2.59e-05	0.000216	CbGpPWpGaD
Diclofenac—ALB—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	2.58e-05	0.000215	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—GSR—amyotrophic lateral sclerosis	2.57e-05	0.000214	CbGpPWpGaD
Diclofenac—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	2.54e-05	0.000212	CbGpPWpGaD
Diclofenac—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	2.54e-05	0.000212	CbGpPWpGaD
Diclofenac—ABCC1—Disease—CST3—amyotrophic lateral sclerosis	2.52e-05	0.00021	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.51e-05	0.000209	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—CHAT—amyotrophic lateral sclerosis	2.5e-05	0.000208	CbGpPWpGaD
Diclofenac—CXCL8—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	2.49e-05	0.000208	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.49e-05	0.000208	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.49e-05	0.000208	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—IGF1—amyotrophic lateral sclerosis	2.48e-05	0.000207	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	2.45e-05	0.000204	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.43e-05	0.000203	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.41e-05	0.000201	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.38e-05	0.000199	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	2.37e-05	0.000198	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.36e-05	0.000197	CbGpPWpGaD
Diclofenac—ALB—Metabolism—DAO—amyotrophic lateral sclerosis	2.36e-05	0.000197	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.36e-05	0.000197	CbGpPWpGaD
Diclofenac—PTGS2—Disease—VCP—amyotrophic lateral sclerosis	2.35e-05	0.000196	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	2.34e-05	0.000195	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.34e-05	0.000195	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	2.33e-05	0.000194	CbGpPWpGaD
Diclofenac—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.3e-05	0.000192	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	2.29e-05	0.000191	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	2.28e-05	0.000191	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	2.28e-05	0.000191	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.28e-05	0.00019	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.27e-05	0.00019	CbGpPWpGaD
Diclofenac—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.27e-05	0.000189	CbGpPWpGaD
Diclofenac—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	2.26e-05	0.000189	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PLB1—amyotrophic lateral sclerosis	2.21e-05	0.000184	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.2e-05	0.000183	CbGpPWpGaD
Diclofenac—PTGS2—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	2.2e-05	0.000183	CbGpPWpGaD
Diclofenac—ALB—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	2.18e-05	0.000182	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	2.15e-05	0.000179	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	2.14e-05	0.000178	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.13e-05	0.000178	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PLB1—amyotrophic lateral sclerosis	2.13e-05	0.000177	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	2.12e-05	0.000177	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—CHAT—amyotrophic lateral sclerosis	2.11e-05	0.000176	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	2.09e-05	0.000174	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.08e-05	0.000174	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.08e-05	0.000174	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	2.07e-05	0.000173	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.06e-05	0.000172	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—GSR—amyotrophic lateral sclerosis	2.04e-05	0.00017	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—APOE—amyotrophic lateral sclerosis	1.98e-05	0.000165	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	1.98e-05	0.000165	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.96e-05	0.000164	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.96e-05	0.000164	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—GSR—amyotrophic lateral sclerosis	1.96e-05	0.000164	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.94e-05	0.000162	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.94e-05	0.000162	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	1.93e-05	0.000161	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.93e-05	0.000161	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—GSR—amyotrophic lateral sclerosis	1.92e-05	0.00016	CbGpPWpGaD
Diclofenac—TTR—Disease—PTGS2—amyotrophic lateral sclerosis	1.9e-05	0.000158	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.86e-05	0.000155	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.85e-05	0.000154	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—SOD1—amyotrophic lateral sclerosis	1.84e-05	0.000154	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.83e-05	0.000153	CbGpPWpGaD
Diclofenac—ABCC1—Disease—CASP9—amyotrophic lateral sclerosis	1.83e-05	0.000153	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	1.83e-05	0.000152	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—GSR—amyotrophic lateral sclerosis	1.81e-05	0.000151	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	1.8e-05	0.00015	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PLB1—amyotrophic lateral sclerosis	1.79e-05	0.000149	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	1.78e-05	0.000148	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	1.76e-05	0.000147	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	1.76e-05	0.000147	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.76e-05	0.000147	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.73e-05	0.000144	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.71e-05	0.000143	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CST3—amyotrophic lateral sclerosis	1.69e-05	0.000141	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.68e-05	0.00014	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.68e-05	0.00014	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	1.66e-05	0.000139	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	1.65e-05	0.000138	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	1.65e-05	0.000138	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	1.65e-05	0.000138	CbGpPWpGaD
Diclofenac—ALB—Metabolism—GSR—amyotrophic lateral sclerosis	1.65e-05	0.000138	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.65e-05	0.000138	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.62e-05	0.000135	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.62e-05	0.000135	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	1.61e-05	0.000134	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—CHAT—amyotrophic lateral sclerosis	1.61e-05	0.000134	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	1.61e-05	0.000134	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.6e-05	0.000134	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.58e-05	0.000132	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.58e-05	0.000132	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.57e-05	0.000131	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.57e-05	0.000131	CbGpPWpGaD
Diclofenac—ABCC1—Disease—ERBB4—amyotrophic lateral sclerosis	1.57e-05	0.000131	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.56e-05	0.00013	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.55e-05	0.00013	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.53e-05	0.000128	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.51e-05	0.000126	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.5e-05	0.000125	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.5e-05	0.000125	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	1.49e-05	0.000125	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.49e-05	0.000124	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	1.48e-05	0.000124	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	1.46e-05	0.000122	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	1.45e-05	0.000121	CbGpPWpGaD
Diclofenac—ALB—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	1.42e-05	0.000119	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	1.41e-05	0.000118	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	1.4e-05	0.000117	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.4e-05	0.000116	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.39e-05	0.000116	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	1.36e-05	0.000114	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.36e-05	0.000113	CbGpPWpGaD
Diclofenac—ALB—Metabolism—CHAT—amyotrophic lateral sclerosis	1.36e-05	0.000113	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.36e-05	0.000113	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	1.35e-05	0.000113	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.35e-05	0.000113	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.34e-05	0.000112	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—APOE—amyotrophic lateral sclerosis	1.33e-05	0.000111	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.32e-05	0.00011	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.3e-05	0.000108	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—APOE—amyotrophic lateral sclerosis	1.3e-05	0.000108	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.28e-05	0.000107	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	1.27e-05	0.000106	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	1.25e-05	0.000104	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.24e-05	0.000104	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.24e-05	0.000103	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.23e-05	0.000103	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.23e-05	0.000103	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.23e-05	0.000103	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CASP9—amyotrophic lateral sclerosis	1.23e-05	0.000102	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—TP53—amyotrophic lateral sclerosis	1.23e-05	0.000102	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	1.22e-05	0.000102	CbGpPWpGaD
Diclofenac—ABCC1—Disease—APOE—amyotrophic lateral sclerosis	1.21e-05	0.000101	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.19e-05	9.91e-05	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.17e-05	9.8e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.17e-05	9.72e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	1.16e-05	9.63e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.13e-05	9.47e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—IGF1—amyotrophic lateral sclerosis	1.12e-05	9.37e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.11e-05	9.27e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	1.11e-05	9.26e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.07e-05	8.96e-05	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	1.06e-05	8.83e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—APOE—amyotrophic lateral sclerosis	1.05e-05	8.78e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.05e-05	8.77e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—ERBB4—amyotrophic lateral sclerosis	1.05e-05	8.77e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.05e-05	8.73e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.04e-05	8.7e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—APOE—amyotrophic lateral sclerosis	1.02e-05	8.47e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.01e-05	8.45e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	9.66e-06	8.06e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	9.49e-06	7.91e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	9.3e-06	7.76e-05	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.12e-06	7.61e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.01e-06	7.51e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	8.92e-06	7.44e-05	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.88e-06	7.4e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.66e-06	7.22e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	8.66e-06	7.22e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—APOE—amyotrophic lateral sclerosis	8.58e-06	7.16e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	8.53e-06	7.11e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.48e-06	7.07e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	8.48e-06	7.07e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—PTGS2—amyotrophic lateral sclerosis	8.3e-06	6.93e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.28e-06	6.91e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	8.27e-06	6.9e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—APOE—amyotrophic lateral sclerosis	8.13e-06	6.78e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	8e-06	6.67e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.96e-06	6.64e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.91e-06	6.59e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	7.82e-06	6.52e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.79e-06	6.5e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	7.61e-06	6.35e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.35e-06	6.13e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—VEGFA—amyotrophic lateral sclerosis	7.34e-06	6.12e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.33e-06	6.11e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	7.32e-06	6.11e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.29e-06	6.08e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.21e-06	6.02e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.02e-06	5.85e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.95e-06	5.8e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.94e-06	5.79e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—APOE—amyotrophic lateral sclerosis	6.81e-06	5.68e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.74e-06	5.62e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.7e-06	5.59e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—APOE—amyotrophic lateral sclerosis	6.55e-06	5.46e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.54e-06	5.46e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—APOE—amyotrophic lateral sclerosis	6.41e-06	5.35e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.39e-06	5.33e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—APOE—amyotrophic lateral sclerosis	6.05e-06	5.04e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.01e-06	5.02e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.97e-06	4.98e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.93e-06	4.95e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.88e-06	4.9e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.87e-06	4.9e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—TP53—amyotrophic lateral sclerosis	5.54e-06	4.62e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	5.54e-06	4.62e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—APOE—amyotrophic lateral sclerosis	5.51e-06	4.6e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.48e-06	4.57e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.3e-06	4.42e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.1e-06	4.25e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	4.95e-06	4.13e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	4.83e-06	4.03e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.69e-06	3.91e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	4.51e-06	3.76e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.49e-06	3.74e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.39e-06	3.66e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.14e-06	3.46e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.93e-06	3.28e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	3.85e-06	3.22e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.8e-06	3.17e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.78e-06	3.15e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.62e-06	3.02e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.39e-06	2.83e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.31e-06	2.76e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.09e-06	2.58e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	2.98e-06	2.48e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.64e-06	2.2e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.04e-06	1.7e-05	CbGpPWpGaD
